MedTech Dive December 18, 2024
Elise Reuter

Industry experts said profit pressures and M&A contributed to job cuts. They said layoffs will likely continue into next year, but some expect the cuts to slow.

Medtech firms have cut thousands of workers in the last two years, leaving employees wondering what’s to come in 2025.

In the past two months, DNA testing company 23&Me announced plans to cut 200 jobs, orthopedics firm Smith & Nephew announced plans to cut 150 jobs and diabetes tech firm Embecta said it would cut 125 positions after discontinuing its insulin patch pump program.

A MedTech Dive analysis found that there have been more than 14,000 layoffs across the industry from January 2023 to mid-2024.

Profitability pressures, mergers and strategic shifts have...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
Only 20% of AI devices for children used pediatric data to train: 3 notes
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry
Cala Health Snags $50M for At-Home Tremor Relief Therapy
A Lifetime Guarantee on a Shoulder Implant? This Device Maker Is Offering It Through Geisinger

Share This Article